Zepbound vs Mounjaro: Same Tirzepatide, Different Rules

Zepbound and Mounjaro contain the same active ingredient, tirzepatide, but differ in FDA approval, insurance coverage, and pricing. Here's what you need to know.

Share

Zepbound and Mounjaro are both tirzepatide injections, but they're not interchangeable. The same drug, different indications, different costs.

Zepbound is FDA-approved for weight management in adults with obesity or overweight with weight-related conditions. Mounjaro treats type 2 diabetes.

The active ingredient is identical: tirzepatide at the same doses. The difference is in the label, the coverage rules, and your costs.

Insurance covers Mounjaro for diabetes as a prescription medication. Zepbound's coverage depends on your plan: some cover it for weight management, others don't. Out-of-pocket costs vary widely. Mounjaro typically costs less through insurance because it has an established place in diabetes treatment protocols. Zepbound costs more if you're paying out-of-pocket, though patient assistance programs exist.

Doctors can prescribe either drug off-label, but insurance may deny coverage if it doesn't match the approved use. Your pharmacy, your insurance plan, and your indication all determine what you actually pay and whether you can get it at all.

If you're using tirzepatide for weight loss, ask your doctor whether Zepbound or an off-label Mounjaro prescription makes sense for your coverage. If you're treating diabetes, Mounjaro is the on-label choice. Both work the same way. The rules around them don't.

https://ratedbypatients.com/articles/zepbound-vs-mounjaro-same-tirzepatide-different-rules/